Yan Leyfman, Medical Oncologist, Co-Founder and Executive Director of MedNews Week, shared a post on X:
“Exercise as cancer therapy—beyond supportive care
Exercise is emerging as more than a quality-of-life intervention in oncology. Growing evidence suggests it can modulate tumor biology, improve treatment response, and impact survival.
Key challenges:
- Heterogeneous models and interventions
- Limited predictive biomarkers
- Gaps in clinical integration
What’s next:
- Identify molecular effectors of exercise
- Develop biomarker-driven strategies
- Translate exercise from supportive care to a targeted, evidence-based cancer therapy
Takeaway: With mechanistic insight and clinical rigor, exercise could become a precision adjunct in cancer treatment.”
More posts featuring Yan Leyfman.